This is a medicine used to treat malaria. It's a combination of two drugs, artemether and lumefantrine. These drugs work together to fight the malaria parasite inside your body. It's often taken as a single pill.
Every report comes from a Lived member, sent anonymously.
Have you tried Coartem (Artemether-Lumefantrine) for Malaria?
Coartem is a prescription tablet that combines two malaria medicines, artemether and lumefantrine. It treats uncomplicated malaria caused by Plasmodium falciparum, the malaria parasite most likely to become dangerous. Uncomplicated means the person has symptoms such as fever, chills, headache and body aches but no signs that the infection is damaging vital organs. It is approved for adults and for children 2 months and older who weigh at least 5 kg (about 11 pounds), and it works in regions where the parasite has become resistant to the older drug chloroquine. In the United States it is the only combination of this type available, and it is a common choice for travelers diagnosed after returning from a malaria area. Coartem is not used for severe malaria, which is treated in hospital with intravenous artesunate, and it is not used to prevent malaria before or during travel. It also treats the blood stage of P. vivax malaria, but P. vivax and P. ovale can hide in the liver and cause relapses months later, so those infections need a second medicine to clear the liver forms.
Malaria parasites multiply inside red blood cells, and the two ingredients attack them there in different ways. Artemether belongs to the artemisinin family of fast-acting malaria drugs. The body quickly converts it into an active form that kills parasites fast, which is why fever and parasite counts usually fall within the first day or two. It is cleared from the body within hours, though, so it cannot finish the job alone. Lumefantrine works more slowly but lingers for days. It appears to stop the parasite from safely disposing of a toxic by-product of the hemoglobin it digests. Its long staying power mops up the parasites that survive the first rapid hit. Pairing a fast drug with a long-acting partner cures more infections than either drug alone and makes it harder for the parasite to develop resistance.
The FDA label gives a 3-day course of 6 doses: a first dose, a second dose 8 hours later, then one dose every morning and evening for the next 2 days. Adults and anyone weighing 35 kg (about 77 pounds) or more take 4 tablets per dose. Children take 1 to 3 tablets per dose depending on body weight. In 2026 the CDC began recommending a longer 5-day (10-dose) course for people treated in the United States, after reports of infections returning weeks after the standard 3-day course, so a prescriber may give more tablets than the package describes. Follow the schedule on your prescription and take every dose, even after the fever is gone. Take each dose with food or a drink containing some fat, such as milk. Food greatly increases how much medicine the body absorbs, and people who eat very little during treatment are more likely to have the infection come back. For a child who cannot swallow tablets, they can be crushed and mixed with 1 to 2 teaspoons of water just before the dose, followed by milk, formula or other food if possible. If a dose is vomited within 1 to 2 hours, take that dose again. If the repeat dose also comes back up, contact the prescriber the same day, because a different malaria treatment is needed.
Many of the most common complaints overlap with malaria itself: headache, loss of appetite, dizziness, weakness, tiredness, and joint and muscle aches in adults, and fever, cough, vomiting and poor appetite in children. Nausea, stomach pain, trouble sleeping and a sense of a pounding heartbeat also occur. Most of these are mild and fade as the infection clears. Allergic reactions are uncommon. Stop taking it and contact the prescriber right away for a new rash or hives. Swelling of the lips, tongue, face or throat, or trouble breathing or swallowing, can be anaphylaxis, a severe allergic reaction: call 911. A delayed drop in red blood cells (hemolytic anemia) has been reported, mostly in people who first received intravenous artesunate for severe malaria. Unusual tiredness, paleness or dark urine in the weeks after treatment is worth reporting.
Lumefantrine can lengthen the QT interval, a measure on an electrocardiogram (ECG) of how long the heart takes to reset between beats. When it is too long, a dangerous irregular rhythm becomes more likely. Coartem is usually avoided in people with long QT syndrome or a family history of it or of sudden death, a slow heart rate or serious heart disease, or low potassium or magnesium levels. Tell the prescriber about medicines that also affect heart rhythm, including some antiarrhythmics such as amiodarone, some antipsychotics and antidepressants, macrolide antibiotics such as azithromycin, fluoroquinolone antibiotics such as ciprofloxacin, and azole antifungals. Because lumefantrine stays in the body for days, the same caution applies to quinine or similar drugs given soon after the course. Report prolonged palpitations or fainting to the care team right away. Some medicines speed up the breakdown of both ingredients so much that the malaria may not be cured. Coartem should not be taken with rifampin (a tuberculosis antibiotic), the seizure medicines carbamazepine and phenytoin, or the herbal supplement St. John's wort. Several HIV medicines and grapefruit juice can also change levels, so people on HIV treatment need their regimen reviewed. Taking other malaria medicines at the same time is generally avoided. Coartem may make hormonal birth control (pills, patches, rings or implants) less effective. Use condoms or another non-hormonal method during treatment. Studies of more than 1,700 pregnant people, including over 500 in the first trimester, have not shown an increase in birth defects or miscarriage, and untreated malaria is itself dangerous in pregnancy, so anyone pregnant should discuss treatment promptly rather than delay it.
Fever and other symptoms usually start improving within a day or two, and people often feel much better well before the last dose. Finishing the whole course matters because the remaining doses clear parasites that are still in the blood. Clinicians often recheck a blood smear during or after treatment to confirm the parasites are gone, especially if symptoms are slow to settle. The infection can return even after a complete course. In CDC reviews of treatment failures in US travelers, most came back 1 to 8 weeks after treatment. A new fever in the weeks after Coartem needs a prompt malaria test, and the clinician should know about the earlier treatment, since a different medicine is used the second time. Worsening during treatment, such as extreme drowsiness or confusion, a seizure, trouble breathing, or yellowing of the skin or eyes, can mean the infection has become severe and needs emergency care.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Coartem (Artemether-Lumefantrine), what you've noticed, or ask the community a question.